Skip to search formSkip to main contentSkip to account menu

Epoprostenol 1.5 MG Injection

Known as: EPOPROSTENOL NA (EQV-FLOLAN) 1.5MG/VIL INJ, EPOPROSTENOL SODIUM 1.5 mg INTRAVENOUS INJECTION, POWDER, FOR SOLUTION, EPOPROSTENOL (EQV-FLOLAN) 1.5MG/VIL INJ 
National Institutes of Health

Related topics

Related topics

22 relations
Arterial Vasodilation [PE]ArteriosclerosisCongestive heart failureDecreased Blood Pressure [PE]

Narrower (2)

Epoprostenol 1.5 MG Injection [Flolan]Epoprostenol 1.5 MG Injection [Veletri]

Broader (1)

Prostaglandins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.
2011
2011
Use of Inhaled Epoprostenol in Patients with H1N1 Influenza-Associated Acute Respiratory Distress Syndrome: A Case Series
Objective: To report a series of patients with confirmed novel influenza A (H1N1) and refractory hypoxemia secondary to acute… 
2005
2005
epoprostenol が著効したHIV陽性 肺高血圧症の一例(第125回日本循環器学会東海地方会)
2003
2003
Transesophageal echocardiographic diagnosis of carbon dioxide embolism during minimally invasive saphenous vein harvesting and treatment with inhaled epoprostenol.
IMPLICATIONS We describe a patient scheduled for coronary artery bypass who developed carbon dioxide (CO2) embolism with acute… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)